These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26235729)

  • 21. Introduction to the KHA-CARI Guidelines on ADPKD.
    Rangan GK; Savige J
    Semin Nephrol; 2015 Nov; 35(6):521-3. PubMed ID: 26718154
    [No Abstract]   [Full Text] [Related]  

  • 22. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
    Rizk D; Jurkovitz C; Veledar E; Bagby S; Baumgarten DA; Rahbari-Oskoui F; Steinman T; Chapman AB
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):560-6. PubMed ID: 19261830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.
    Joly D; Quinn J; Mokiou S; O'Reilly K; Sánchez-Covisa J; Wang-Silvanto J; Doll H
    BMC Nephrol; 2020 Jul; 21(1):298. PubMed ID: 32709218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients' priorities for health research: focus group study of patients with chronic kidney disease.
    Tong A; Sainsbury P; Carter SM; Hall B; Harris DC; Walker RG; Hawley CM; Chadban S; Craig JC
    Nephrol Dial Transplant; 2008 Oct; 23(10):3206-14. PubMed ID: 18445638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal dominant polycystic kidney disease: a case study.
    Phillips A
    Nephrol Nurs J; 2009; 36(1):41-7. PubMed ID: 19271623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumer involvement in topic and outcome selection in the development of clinical practice guidelines.
    Tong A; Lopez-Vargas P; Howell M; Phoon R; Johnson D; Campbell D; Walker RG; Craig JC
    Health Expect; 2012 Dec; 15(4):410-23. PubMed ID: 23134217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opinions on the content and effects of clinical practice guidelines for CKD: a survey of nephrologists in Australia and New Zealand.
    Irving MJ; Johnson DW; McDonald S; Walker RG; Frommer MS; Craig JC
    Am J Kidney Dis; 2009 Jun; 53(6):1082-90. PubMed ID: 19394725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
    Sautenet B; Cho Y; Gutman T; Rangan G; Ong A; Chapman AB; Ahn C; Coolican H; Tze-Wah Kao J; Fowler K; Gansevoort RT; Geneste C; Perrone RD; Harris T; Torres VE; Pei Y; Craig JC; Tong A;
    Am J Kidney Dis; 2020 Aug; 76(2):213-223. PubMed ID: 32171640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting, refining and identifying priority Cochrane Reviews in health communication and participation in partnership with consumers and other stakeholders.
    Synnot AJ; Tong A; Bragge P; Lowe D; Nunn JS; O'Sullivan M; Horvat L; Kay D; Ghersi D; McDonald S; Poole N; Bourke N; Lannin NA; Vadasz D; Oliver S; Carey K; Hill SJ
    Health Res Policy Syst; 2019 Apr; 17(1):45. PubMed ID: 31036016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Chapman AB; Devuyst O; Eckardt KU; Gansevoort RT; Harris T; Horie S; Kasiske BL; Odland D; Pei Y; Perrone RD; Pirson Y; Schrier RW; Torra R; Torres VE; Watnick T; Wheeler DC;
    Kidney Int; 2015 Jul; 88(1):17-27. PubMed ID: 25786098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient Perspectives on ADPKD.
    Gittus M; Harris T; Ong AC
    Adv Kidney Dis Health; 2023 May; 30(3):294-302. PubMed ID: 37088530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research.
    Tong A; Rangan GK; Ruospo M; Saglimbene V; Strippoli GF; Palmer SC; Tunnicliffe DJ; Craig JC
    Nephrol Dial Transplant; 2015 May; 30(5):790-800. PubMed ID: 25637642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines.
    Haller MC; van der Veer SN; Nagler EV; Tomson C; Lewington A; Hemmelgarn BR; Gallagher M; Rocco M; Obrador G; Vanholder R; Craig JC; van Biesen W
    Nephrol Dial Transplant; 2015 Jul; 30(7):1066-74. PubMed ID: 25204317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease.
    Lacquaniti A; Chirico V; Lupica R; Buemi A; Loddo S; Caccamo C; Salis P; Bertani T; Buemi M
    Peptides; 2013 Nov; 49():1-8. PubMed ID: 23973863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics and Autosomal Dominant Polycystic Kidney Disease Progression.
    Corradi V; Giuliani A; Gastaldon F; de Cal M; Mancini B; Montaldi A; Alghisi A; Capelli I; La Manna G; Ronco C
    Contrib Nephrol; 2017; 190():117-123. PubMed ID: 28535524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "An evil heritage": interview study of pain and autosomal dominant polycystic kidney disease.
    Heiwe S; Bjuke M
    Pain Manag Nurs; 2009 Sep; 10(3):134-41. PubMed ID: 19706350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function.
    Lee DI; Andreoni CR; Rehman J; Landman J; Ragab M; Yan Y; Chen C; Shindel A; Middleton W; Shalhav A; McDougall EM; Clayman RV
    J Endourol; 2003 Aug; 17(6):345-54. PubMed ID: 12965058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
    Smith KA; Thompson AM; Baron DA; Broadbent ST; Lundstrom GH; Perrone RD
    Am J Kidney Dis; 2019 Apr; 73(4):533-541. PubMed ID: 30600104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.